Dutch Biotech Touts Enzyme-Powered Eczema Cream As ‘Smarter And Safer’ Solution
Headquartered in The Hague, Netherlands, Micreos is focused on developing targeted antibacterial products to replace antibiotics, protect against food contamination and treat inflammatory skin conditions. The firm’s Gladskin Eczema Cream, now available stateside, uses a patented enzyme technology to destroy Staphylococcus aureus bacteria while leaving skin’s beneficial flora intact.
You may also be interested in...
Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions.
Nakissa Sadrieh, director of cosmetics at FDA and the agency’s CIR liaison, floated the three potential review priorities at the CIR Expert Panel’s April 8-9 meeting in Washington. It’s the most for-cause targets proposed by the agency in recent memory, and CIR leadership noted that they pose considerable challenges.
Gwyneth Paltrow’s Goop, Inc. demonstrated to the National Advertising Division’s satisfaction that Madame Ovary is “a daily regimen formulated to support thyroid health and smoothing the menopausal transition by providing nutritional support for women who may experience mild hot flashes, mood shifts, and stress-related fatigue.” Other ingredient-specific claims came up short.